[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AbbVie Inc - Company Snapshot & SWOT Analysis

March 2019 | 27 pages | ID: A80DA5CB7FBEN
NAVADHI Market Research Pvt Ltd

US$ 200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. The company operates in more than 75 countries.

AbbVie’s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson’s disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neurology, with additional targeted investment in cystic fibrosis and women’s health.

AbbVie Inc. reported revenue of USD 32.733 billion for the FY 2018 which saw an increase of 16% compared to FY 2017.

Company's global sales were impacted by the launch of several direct biosimilar drugs. These drugs are launched at much cheaper price anticipated by AbbVie resulting decline in sales in Europe and other international markets.

AbbVie Inc. registered highest revenue from immunology (Humira) at USD 19.936 billion. Humira continue to perform better in the U.S. market, drug sales are expected to rise approximately 7% in 2019, which is less than growth of 10% in 2018 due to lighter price contribution for the year.

Spanning over 27 pages and 10 exhibits, “AbbVie Inc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the AbbVie Inc - Company Snapshot & SWOT Analysis Report
  • This report provides detailed information about AbbVie Inc including value chain analysis, financial performance, business strategy and SWOT analysis.
  • The report identifies the growth drivers and inhibitors for global pharmaceutical market.
  • This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY

Scope of the AbbVie Inc.- Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 AbbVie Inc.
  3.1.1 Company Profile
  3.1.2 AbbVie Inc. in Global Pharmaceuticals Manufacturing Value Chain
  3.1.3 AbbVie Inc.: Financial Performance
    3.1.3.1 AbbVie Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)
    3.1.3.2 AbbVie Inc.: Geography-Wise Revenue FY 2018 (in USD billion)
    3.1.3.3 AbbVie Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)
  3.1.4 AbbVie Inc.: Business Strategy
    3.1.4.1 Product Level Strategy
  3.1.5 SWOT Analysis of AbbVie Inc.
Strengths
Weaknesses
Opportunities
Threats

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Company Information

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key information of AbbVie Inc.
Exhibit 3.2 Contact Information of AbbVie. Inc.
Exhibit 3.3 AbbVie. Inc. in Global Pharmaceuticals Manufacturing Value Chain
Exhibit 3.4 Revenue of AbbVie Inc. FY 2013- FY 2019 (in USD billion)
Exhibit 3.5 Revenue Growth of AbbVie Inc. FY 2014-FY 2019 (in %)
Exhibit 3.6 Geography-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)
Exhibit 3.7 Therapy Area-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)
Exhibit 3.8 Therapy Area and Geography Area-Wise Revenue of AbbVie Inc. FY 2018 (in USD billion)
Exhibit 3.9 SWOT Analysis of AbbVie Inc.


More Publications